|
Sign In to gain access to subscriptions and/or personal tools.
|
Characterization of an In Vitro Platelet Function Analyzer, PFA-100TM
Sourav K. Kundu, Ph.D.
Dade International, Inc., Miami, Florida, U.S.A.
Eric J. Heilmann, Ph.D.
Dade International, Inc., Miami, Florida, U.S.A.
Reynaldo Sio, M.S.
Dade International, Inc., Miami, Florida, U.S.A.
Carmen Garcia, B.S.
Dade International, Inc., Miami, Florida, U.S.A.
Roy A. Ostgaard, B.S.
Dade International, Inc., Miami, Florida, U.S.A.
A new in vitro system for the evaluation of platelet function, PFA-100 (currently under evaluation) is characterized. The system monitors platelet aggrega tion on a collagen-epinephrine-coated membrane as whole blood sample is aspirated under controlled flow conditions through a microscopic aperture cut into the membrane. The time required for the platelet plug to oc clude the aperture (closure time) is indicative of the plate let function in the sample. Incubation of normal blood samples with antibodies to glycoprotein (GP) Ib, GPIIb- IIIa, von Willebrand factor, or with the peptide Arg-Gly- Asp-Ser, resulted in a concentration-dependent prolonga tion in closure time. An anti-fibrinogen antibody did not impact the closure time. Closure time was also prolonged when the hematocrit or the platelet count was lowered to pathological values. The study indicates that PFA-100 could detect defects in platelet adhesion or aggregation. The simplicity of the test makes PFA-100 unique for rapid screening of a variety of platelet dysfunction.
Key Words: Key Words: Platelet function • Test • In vitro • Analyzer • Blood.
Clinical and Applied Thrombosis/Hemostasis, Vol. 2, No. 4,
241-249 (1996)
DOI: 10.1177/107602969600200404
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
S Wiegand, B Eivazi, R Karger, B Al Kadah, A M Sesterhenn, and J A Werner
Surgery in patients with vascular malformations of the head and neck: value of coagulation disorders
Phlebology,
February 1, 2009;
24(1):
38 - 42.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Monagle, E. Chalmers, A. Chan, G. deVeber, F. Kirkham, P. Massicotte, and A. D. Michelson
Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest,
June 1, 2008;
133(6_suppl):
887S - 968S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Monagle, A. Chan, P. Massicotte, E. Chalmers, and A. D. Michelson
Antithrombotic Therapy in Children*: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest,
September 1, 2004;
126(3_suppl):
645S - 687S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V.L. Serebruany, A.H. Glassman, A.I. Malinin, D. Atar, D.C. Sane, B.R. Oshrine, J.J. Ferguson, and C.M. O'Connor
Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin
Eur J Heart Fail,
August 1, 2003;
5(4):
517 - 521.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. W. Stief and J. Fareed
Point of Care: Diagnostics in Hemostasisthe Wrong Direction?
Clinical and Applied Thrombosis/Hemostasis,
July 1, 2003;
9(3):
191 - 195.
[Abstract]
[PDF]
|
|
|
|
|
|
|
V.L. Serebruany, M.E. McKenzie, A.F. Meister, S.Y. Fuzaylov, P.A. Gurbel, D. Atar, W.A. Gattis, and C.M. O'Connor
Whole blood impedance aggregometry for the assessment of platelet function in patients with congestive heart failure (EPCOT Trial)
Eur J Heart Fail,
August 1, 2002;
4(4):
461 - 467.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Kottke-Marchant, J. B. Powers, L. Brooks, S. Kundu, and D. J. Christie
State-of-the-Art Review : The Effect of Antiplatelet Drugs, Heparin, and Preanalytical Variables on Platelet Function Detected by the Platelet Function Analyzer (PFA-100(R))
Clinical and Applied Thrombosis/Hemostasis,
April 1, 1999;
5(2):
122 - 130.
[Abstract]
[PDF]
|
|
|
|
|
